Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
India
Manufacturing
Aurobindo's Eugia tallies a 5th Form 483 in less than a year
Eugia remains under FDA scrutiny as the unit of Indian drugmaker Aurobindo tallied a fifth Form 483 from the regulator since December.
Joseph Keenan
May 14, 2024 9:40am
The FDA serves up warning letters to pair of Indian pharmas
Apr 10, 2024 9:58am
Jubilant Generics, Contract Pharmaceuticals hit with Form 483s
Apr 9, 2024 8:22am
Sanofi pledges to keep polio vaccine supplies afloat in India
Apr 4, 2024 4:25pm
Sanofi calls on 3 drugmakers to market its meds overseas
Mar 27, 2024 9:57am
Indian CDMOs Suven Pharma, Cohance Lifesciences plan merger
Mar 5, 2024 8:30am